price
ZN
NASDAQ · ZNTL
Zentalis Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.96
Down-$0.03 (-1.51%)
Updated Nov 2, 2026, 2:21 PM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 104.4M
- P/E ratio
- -0.64
- Dividend yield
- 0.00%
- 52-week range
- $1.21 – $6.95
- Volume
- 1.33M
- Avg. volume
- 673.52K
Price performance · ZNTL
ZNTL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ZNTL closed at $1.96 after 20 trading sessions, down 29.50% for the selected period.
- Last close
- $1.96
- Period change
- -29.50%
- Period low
- $1.96
- Period high
- $2.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.99 | $1.99 | $1.86 | $1.96 | 1.33M |
| Oct 29, 2026 | $2.06 | $2.11 | $1.97 | $1.99 | 1.45M |
| Oct 28, 2026 | $1.99 | $2.095 | $1.98 | $2.06 | 2.2M |
| Oct 27, 2026 | $2.07 | $2.118 | $1.96 | $1.98 | 1.72M |
| Oct 26, 2026 | $2.21 | $2.27 | $2.03 | $2.07 | 1.06M |
| Oct 23, 2026 | $2.41 | $2.41 | $2.18 | $2.21 | 947.07K |
| Oct 22, 2026 | $2.33 | $2.43 | $2.29 | $2.41 | 746.23K |
| Oct 21, 2026 | $2.36 | $2.47 | $2.34 | $2.36 | 1.21M |
| Oct 20, 2026 | $2.31 | $2.4399 | $2.25 | $2.39 | 1.56M |
| Oct 19, 2026 | $2.33 | $2.3557 | $2.07 | $2.30 | 2.74M |
| Oct 16, 2026 | $2.25 | $2.30 | $2.10 | $2.13 | 1.1M |
| Oct 15, 2026 | $2.27 | $2.3963 | $2.21 | $2.24 | 2.03M |
| Oct 14, 2026 | $2.44 | $2.45 | $2.30 | $2.32 | 865.65K |
| Oct 13, 2026 | $2.53 | $2.54 | $2.39 | $2.40 | 570.1K |
| Oct 12, 2026 | $2.64 | $2.64 | $2.51 | $2.52 | 546.55K |
| Oct 9, 2026 | $2.56 | $2.6589 | $2.5112 | $2.64 | 612.37K |
| Oct 8, 2026 | $2.51 | $2.535 | $2.39 | $2.51 | 1.27M |
| Oct 7, 2026 | $2.63 | $2.68 | $2.54 | $2.55 | 820.08K |
| Oct 6, 2026 | $2.81 | $2.8199 | $2.65 | $2.67 | 827.9K |
| Oct 5, 2026 | $2.69 | $2.8399 | $2.63 | $2.78 | 2.99M |
Latest ZNTL news
The latest Smart Investors Daily articles mentioning ZNTL.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

